- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02180620
Pre-dinner vs. Post-dinner Exercise on Glycemic Control
June 6, 2017 updated by: Jill Kanaley, University of Missouri-Columbia
Exercise Timing and Postprandial Glycemia in Type 2 Diabetes
With many medications we prescribe them relative to time of day or a meal.
This study established if pre dinner vs post dinner exercise was more effective at altering post dinner glucose and triglyceride levels vs no exercise at all.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All participants completed three trials in a random order in which they consumed a standardized dinner meal with 1) no RE (NoRE), 2) pre-dinner RE (RE→M), and 3) post-dinner RE beginning 45 min after dinner (M→RE).
Diet was standardized during the day of testing.
Participants reported to the lab for testing sometime between 3 - 5:30 p.m. and upon arrival a venous catheter was inserted into a forearm vein.
Frequent blood sampling, indirect calorimetry measurements, and subjective well-being measurements ensued for ~5.75 h while the participants were in the lab.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Obese ( body mass index 30-45 kg/m2)
- Physician diagnosed with type 2 diabetes receiving standard medical care
- Non-smokers
- Pregnancy
- Lactating mothers
Exclusion Criteria:
- Insulin
- Surgical weight loss
- Orthopedic limitations to exercise
- Weight loss in the previous 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: No exercise
participants will remain sedentary during testing
|
During the no exercise trial (NoEX), the participants will remain sedentary during testing.
Other Names:
|
Experimental: Meal then exercise
45 min of resistance training will be performed after a standard meal
|
During the post-meal exercise trial (M→EX), 45 min of resistance training will be performed
Other Names:
|
Experimental: exercise then meal
45 min of resistance training will be performed prior to a standard meal
|
During the exercise prior to the meal trial (EX→M), 45 min of resistance training will be performed
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
glucose concentrations
Time Frame: Blood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h
|
Blood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
triglyceride concentrations
Time Frame: Blood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h
|
Blood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
GLP-1 concentrations
Time Frame: Blood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h
|
Blood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
June 30, 2014
First Submitted That Met QC Criteria
July 1, 2014
First Posted (Estimate)
July 2, 2014
Study Record Updates
Last Update Posted (Actual)
June 8, 2017
Last Update Submitted That Met QC Criteria
June 6, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- exertime
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on No exercise
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS)Recruiting
-
Astellas Pharma IncCompleted
-
Hillel Yaffe Medical CenterUnknownMacroscopic and Molecular Changes in Knee Muscular - Tendon Unit in Response to Acute Resistant LoadPhysical ExertionIsrael
-
Texas Tech University Health Sciences Center, El...Completed
-
USDA Grand Forks Human Nutrition Research CenterWithdrawn
-
University of AlbertaWomen and Children's Health Research Institute, CanadaRecruitingType 1 Diabetes | Post-menopauseCanada
-
University of Missouri-ColumbiaCompletedOsteoporosis | Osteopenia
-
University of WashingtonCompletedDepression | Traumatic Brain InjuryUnited States
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedHyperglycemia | Diabetes Mellitus, Type 2Netherlands
-
University of Missouri-ColumbiaCompleted